Puma Biotechnology Announces $10 Million Private Placement – businesswire.com

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (the Company) (Nasdaq: PBYI), a biopharmaceutical company, announced that it has entered into a securities purchase agreement with Alan H Auerbach, the Company’s Chief Executive Officer, President and Chairman...

Peer review affirms MiSight® 1 day sustains slowing of eye growth over six years...

SAN RAMON, CALIF., March 10, 2022—A new peer review paper affirms that CooperVision® MiSight® 1 day contact lenses provide myopia control for nearly all children.†1 In the longest-running soft contact lens study among children,...

Cancer Cell Iron Addiction Exploited to Target Drug Conjugate to Tumors

Researchers at the University of California, San Francisco (UCSF) have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and...

Low profile microplates optimise space utilisation

Porvair Sciences low profile microplates offer the highly efficient use of stacking space that is essential to achieving efficient automation workflows. Image Credit: Porvair Sciences Related StoriesDesigned to deliver a sample volume of 0.5...

UQ and Moderna partner to research and develop vaccines against global public health threats

The University of Queensland has been selected as one of the first launch institutions in the world to partner with biotechnology company Moderna to research and develop vaccines to tackle the world's greatest global...

Damage to general intelligence brain networks makes it difficult for dementia patients to cope...

People with dementia struggle to adapt to changes in their environment because of damage to areas of the brain known as 'multiple demand networks', highly-evolved areas of the brain that support general intelligence, say...

AVM Biotechnology Expands C-Suite in Anticipation of 2023 Commercialization Efforts – Maryville Daily Times

SEATTLE--(BUSINESS WIRE)--Mar 9, 2022--AVM Biotechnology, a clinical stage company developing AVM0703, a small molecule that mobilizes endogenous gamma delta TCR+ and invariant TCR+ bispecific Natural Killer T-like cells, announced the expansion of its...

Pasqal and ARAMCO collaborate to develop quantum computing applications for the energy industry

Riyadh, March 9, 2022 – Pasqal, a developer of neutral atom-based quantum technology, and ARAMCO announced the signing of an MoU to collaborate on quantum computing capabilities and applications in the energy sector. Objectives...

Memory Encoding Disrupted by Decoupled Astrocyte Networks in Mice

In the brains of adult mice, communication through astrocyte networks controls the formation of spatial memories and plasticity in the hippocampus, a new study led by scientists at the Institute of Pharmacology and Toxicology...

Illinois Tech receives $2.17 million NIH grant to develop drug treatments for cholera

Illinois Institute of Technology is receiving a four-year grant from the National Institutes of Health (NIH) to fund research to develop drug treatments for cholera and other multi-drug-resistant strains of disease-causing bacteria. The $2.17...